What was the result of the ENCHANTED study?
The ENCHANTED (Enhanced Control of Hypertension and Thrombolysis Stroke Study) randomized 2196 alteplase-eligible patients with AIS and systolic BP (SBP) 150 mmHg to receive intensive target SBP of 130 to 140 mmHg within 1 hour versus guideline target SBP <180 mmHg. The primary outcome mRS score at 90 days did not differ between the two groups.